Evidence map›Paper›PMID 28679693›Full record

ArticleCold Spring Harbor molecular case studies2017

Functional validation reveals the novel missense V419L variant in

Margot A Cousin, Michael T Zimmermann, Angela J Mathison, Patrick R Blackburn, Nicole J Boczek, Gavin R Oliver, Gwen A Lomberk, Raul A Urrutia, David R Deyle, Eric W Klee

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Identification of a PathogenicFrontiers in genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Margot A CousinDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Michael T ZimmermannDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Angela J MathisonLaboratory of Epigenetics and Chromatin Dynamics, Gastroenterology Research Unit, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Patrick R BlackburnDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, Florida 32224, USA.
Nicole J BoczekDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Gavin R OliverDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Gwen A LomberkLaboratory of Epigenetics and Chromatin Dynamics, Gastroenterology Research Unit, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Raul A UrrutiaCenter for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
David R DeyleCenter for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Eric W KleeDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
NIDDK NIH HHS R01 DK052913
6 · The paper itself

Abstract

TGF-β-related heritable connective tissue disorders are characterized by a similar pattern of cardiovascular defects, including aortic root dilatation, mitral valve prolapse, vascular aneurysms, and vascular dissections and exhibit incomplete penetrance and variable expressivity. Because of the phenotypic overlap of these disorders, panel-based genetic testing is frequently used to confirm the clinical findings. Unfortunately in many cases, variants of uncertain significance (VUSs) obscure the genetic diagnosis until more information becomes available. Here, we describe and characterize the functional impact of a novel VUS in the

Indexed as

AdultHumansLoeys-Dietz SyndromeMaleMarfan SyndromeMutationMutation, MissensePhosphorylationProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IISignal TransductionSmad2 ProteinTransforming Growth Factor betaProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IISmad2 ProteinSMAD2 protein, humanTransforming Growth Factor betaaneurysm of an abdominal arteryaortic root dilatationarterial tortuosityarthralgia/arthritisdental crowdingdolichocephalyhip subluxationinguinal herniajoint laxitymalar flatteningpes planusshoulder subluxation

Identifiers

PMID28679693
PMCPMC5495030
OpenAlexW2607039193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.